Demant A/S (OTCMKTS:WILYY) Shares Gap Down - Here's What Happened

Key Points

• Demant A/S shares experienced a gap down at market opening, from a previous close of $19.25 to $18.52, with only 100 shares traded at the latter price.
• Barclays upgraded Demant A/S from a "strong sell" to a "hold" rating, while Citigroup upgraded it from "hold" to "strong-buy," resulting in a consensus rating of "Buy" from analysts.
• The company operates in the hearing healthcare and audio technology industry, with key segments focused on hearing aids and diagnostic services, indicating robust market engagement in Europe, North America, and Asia.

Demant A/S Unsponsored ADR (OTCMKTS:WILYY - Get Free Report) shares gapped down before the market opened on Wednesday . The stock had previously closed at $19.25, but opened at $18.52. Demant A/S shares last traded at $18.52, with a volume of 100 shares traded.

Wall Street Analysts Forecast Growth

WILYY has been the subject of several research reports. Citigroup raised Demant A/S from a "hold" rating to a "strong-buy" rating in a research note on Thursday, June 5th. Barclays upgraded Demant A/S from a "strong sell" rating to a "hold" rating in a report on Friday, June 20th. Two research analysts have rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Buy".

Demant A/S Price Performance

The company has a debt-to-equity ratio of 1.29, a quick ratio of 1.22 and a current ratio of 1.63. The firm has a 50-day moving average of $19.49 and a two-hundred day moving average of $19.01.

Demant A/S Company Profile

Demant A/S operates as a hearing healthcare and audio technology company in Europe, North America, the Asia Pacific, Asia, and internationally. It operates through two segments: Hearing Healthcare and Communications. The Hearing Healthcare segment is involved in the manufacturing, servicing, and sale of hearing aids, and diagnostic products and services.